Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
jiegu qili
- Development stage
- Unknown
- Lead developer
- Guangdong Jiaying Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
JieGuQiLi is a Traditional Chinese Medicine (TCM) formulation primarily indicated for the treatment of bone fractures, contusions, and soft tissue injuries. It is a complex multi-ingredient product typically containing processed *Strychnos nux-vomica*, *Carthamus tinctorius* (Safflower), *Daemonorops draco* (Dragon's blood), *Boswellia carterii* (Frankincense), *Commiphora myrrha* (Myrrh), *Pyrite* (Natural Copper), and *Eupolyphaga sinensis* (Ground Beetle). The drug functions by promoting blood circulation, resolving blood stasis, and providing analgesic effects. It is clinically utilized to accelerate the formation of bone callus, reduce local inflammation, and alleviate pain associated with orthopedic trauma. In China, it is a standard pharmaceutical product used in integrated traditional and Western medicine for fracture management.
- Brand names
- Jiegu Qili SanJiegu Qili PianJiegu Qili Jiaonang
- Other names
- 接骨七厘Jiegu Qili PowderJiegu Qili TabletJiegu Qili Capsule
02
Targets
Beyond the preview
Go deeper on jiegu qili.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on jiegu qili.